DNA Immunization for HIV Vaccine Development

By Chen Yuxin   Wang Shixia   Lu Shan  

Vaccines, Vol. 2, Iss. 1, 2014-02 ,pp. : 138-159

MDPI

Access to resources Recommend Favorite

From Variation of Influenza Viral Proteins to Vaccine Development

By Zhu Wandi   Wang Chao   Wang Bao-Zhong  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1554-1554

MDPI

Access to resources Recommend Favorite

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group

By Pleyer Lisa   Döhner Hartmut   Dombret Hervé   Seymour John F.   Schuh Andre C.   Beach CL   Swern Arlene S.   Burgstaller Sonja   Stauder Reinhard   Girschikofsky Michael   Sill Heinz   Schlick Konstantin   Thaler Josef   Halter Britta   Machherndl Spandl Sigrid   Zebisch Armin   Pichler Angelika   Pfeilstöcker Michael   Autzinger Eva M.   Lang Alois   Geissler Klaus   Voskova Daniela   Sperr Wolfgang R.   Hojas Sabine   Rogulj Inga M.   Andel Johannes   Greil Richard  

International Journal of Molecular Sciences, Vol. 18, Iss. 2, 2017-02 ,pp. : 415-415

MDPI

Access to resources Recommend Favorite

Preclinical and Clinical Development of a YFV 17 D-Based Chimeric Vaccine against West Nile Virus

By Dayan Gustavo H.   Pugachev Konstantin   Bevilacqua Joan   Lang Jean   Monath Thomas P.  

Viruses, Vol. 5, Iss. 12, 2013-12 ,pp. : 3048-3070

MDPI

Access to resources Recommend Favorite

Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation

By Lowes Lori E.   Bratman Scott V.   Dittamore Ryan   Done Susan   Kelley Shana O.   Mai Sabine   Morin Ryan D.   Wyatt Alexander W.   Allan Alison L.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1505-1505

MDPI

Access to resources Recommend Favorite